Original Research P arkinson disease (PD) is a nigrostriatal disease 1,2 that also affects other neural structures such as the hippocampus, hypothalamus, medulla, mesopontine, and substance P neurons. 1-3 Symptoms associated with PD include bradykinesia (slowness of movement), tremor, rigidity, postural abnormalities, 4-6 respiratory muscle weakness and disrhythmias, 4, 7, 8 and laryngeal muscle defects. 4,9 Dysphagia, which is characterized in part by a discoordination between respiration and the pharyngeal phase of swallowing, has been considered a strong indicator for aspiration pneumonia risk. [10] [11] [12] Currently, aspiration pneumonia is cited as the leading cause of death in patients with PD; moreover, 
were rated as Hoehn and Yahr stage II to III; showed they were oriented to person, place, and time; were able to complete threestep directions; and scored at minimum 24 on the Mini Mental State Examination. 31 The exclusionary criteria included history of stroke, pulmonary disease, history of dementia, or tobacco use within the last 5 years. A review of medications was performed to verify that no participants were taking medication that interfered with cough production (eg, codeine or morphine). The study protocol was completed with all participants in the "on" medication condition, and participants reported feeling "on" during the time of the examination. The institutional review board at the University of Florida approved the study (IRB 154-2003) .
Equipment and Procedures
Videofl uorographic Examination of Swallow: Participants were seated in an upright position and asked to swallow 3 oz of a thin liquid (Varibar; E-Z-Em; Lake Success, NY) in a continuous manner. A qualifi ed speech-language pathologist with extensive training in evaluating videofl uorographic examination of swallow (VFSE) images (J. R.) measured the degree of PA from the VFSE image of the sequential swallow task using the PA scale ( Table 1 ) . 32 The PA scale is a measure developed and used by speech-language pathologists for the evaluation of pharyngeal dysphagia [32] [33] [34] [35] [36] [37] and has been reported as a reliable measure among clinicians with extensive training. 34, 38 The PA scale score was defi ned as the highest degree of PA as visually judged during the swallow task. All of the VFSE data were archived using the Digital Swallow Station Model 7200 (Kay Elemetrics Corp; Lincoln Park, NJ).
Voluntary Cough Airfl ow Measures:
Airfl ow produced during voluntary cough production was sampled using an oral pneumotachograph (MLT 1000; ADInstruments, Inc; Colorado Springs, CO) connected to a spirometer (ML141, ADInstruments, Inc). A nose clip was placed on participants to occlude nasal airfl ow during the cough maneuver. The airfl ow signal was measured and digitized at 1 kHz and displayed using Chart, version 5 for Windows (Microsoft Corp; Redmond, WA). Each airfl ow sample was low-pass fi ltered at 150 Hz within the Chart software program. The signal was calibrated using a known volume and imported into the recording system. The instructions given to participants during the cough measurement included the following: (1) "relax and breathe into the pneumotachograph tube" (held by the researcher), and (2) "take a deep breath and cough hard," which was verbally instructed following three tidal volume breaths. Each participant completed three separate voluntary cough trials into the pneumotachograph tube. Means and SDs were calculated from the three trials of the voluntary cough using four cough airfl ow measures.
nearly all people with PD will experience some difficulty with feeding and swallowing. 13, 14 Cough is an airway protective mechanism that creates a "scrubbing" action by generating high expiratory airfl ows to remove unwanted material from the airway. [15] [16] [17] To generate high linear airfl ows during cough, there is a need for three distinct phases: an inspiratory phase (involving the chest wall and laryngeal inspiratory muscles), a compression phase (involving laryngeal closure and the abdominal expiratory muscles), and an expulsive phase (involving the chest wall and abdominal expiratory muscles). Additionally, during the expiratory phase, the time it takes to achieve the peak expiratory fl ow is important because the acceleration of the air during this phase is related to the ability of the cough to remove material from the airway. [15] [16] [17] Several factors associated with the progression of PD, beyond neurologic change alone, can impact overall cough effectiveness. Chest wall rigidity can decrease lung infl ation, which in turn affects the inspiratory and expiratory phases of the cough production. 18 Vocal fold bowing, a common symptom in PD, can cause incomplete glottal closure, affecting the buildup of subglottic pressure, the compression phase, and the peak airfl ow of the expiratory phase. [19] [20] [21] The evaluation of dystussia (disorder of cough) has become an important part of the traditional swallow evaluation. [22] [23] [24] Methods of analysis such as integrated electromyographic recordings of surface abdominal muscles 4, 17 and airfl ow 15, [25] [26] [27] [28] have been used. Pitts et al 26 previously examined voluntary cough production using an airfl ow waveform produced by a cohort of 20 male patients with PD. The results of this study revealed that penetration/aspiration (PA) into the airway during swallow were associated with an impaired voluntary cough. Additionally, the study revealed signifi cantly longer compression phase duration (CPD), reduced expiratory phase rise time (EPRT), decreased expiratory phase peak fl ow (EPPF), and decreased cough volume acceleration (CVA) when compared with patients with PD who did not exhibit PA. Unfortunately, because of the small cohort size, other analyses could not be conducted. Based on the results of this study, it was hypothesized that in a larger cohort of people with PD, portions of the voluntary cough airfl ow analysis (CPD, EPPF, EPRT, and CVA) may be used to detect the presence of PA.
Materials and Methods
Fifty-eight participants with idiopathic, dopamine-responsive PD were included in the study. A neurologist with specialization in movement disorders (M. S. O.) determined the diagnosis of PD using the UK Brain Bank Criteria 29 and evaluated the disease stage using the Hoehn and Yahr Staging Scale. 30 All participants (scale score, 1) compared with PA (scale score, 2-8); and PA (scale score, 1-5) compared with PA (scale score, 6-8). ROCs, with measures of sensitivity and specifi city, are used to determine the validity of the screening test to discriminate the presence and absence of the condition. Sensitivity is used to measure the ability of the test to determine a positive test result when the condition is present, and specifi city is used to measure the ability of the test to determine a negative test result when the condition is not present. The ROC is a graphic depiction of sensitivity vs 1-specifi city; the curve demonstrates the trade-off between sensitivity and specifi city and is used to help decide the optimal cutoff point (the threshold with the most desirable ratio of false positive to false negative). 39 Area under the curve (AUC), a measure of the accuracy of the screening tool, is used for the detection of the desired disease. 39 
Results
Of the 58 participants with PD (42 men and 16 women), 13 (22%) were judged to have penetration to the level of the vocal folds, and fi ve (8.6%) aspirated during the sequential swallow task.
ROC Analysis

PA Scale Score of 1 (No Presence of PA) vs PA Scale Scores of 2 to 8 (Presence of PA):
All four of the cough airfl ow-dependent variables were signifi cantly different than chance for the detection of the presence of PA ( Table 2 ) 
PA Scale Scores of 1 to 5 (Penetration) vs PA Scale
Scores of 6 to 8 (Aspiration): EPPF was signifi cantly different than chance for the detection of aspiration, with an AUC of 0.88 ( P , .001) ( Fig 3, Table 3 ). Intrameasurer reliability and intermeasurer reliability for the PA scores and the measurements made from the cough fl ow signals were assessed using intraclass correlation coeffi cients. The intrameasurer ratings were signifi cant for reliability for the PA scale scores ( a 5 0.57, P 5 .001) and the measurements from the cough fl ow signals ( a 5 0.71, P , .001). The intermeasurer ratings were signifi cant for reliability for the PA scale scores ( a 5 0.69, P , .001) and the measurements from the cough fl ow signals ( a 5 0.79, P , .001).
The following measures were derived from the cough fl ow waveform ( Fig 1 ): 1. CPD: the time from the end of the inspiratory phase to the beginning of the expiratory phase. 2. EPRT: the time from the beginning of the expiratory phase to the peak expiratory fl ow. 3. EPPF: the peak airfl ow during the expiratory phase of the cough. 4. CVA: EPPF/EPRT.
Analysis
Initially, intrarater reliability was calculated on 100% of the dataset for the assessment of the PA scale score and 20% of the dataset for the measures of the voluntary cough. Analysis of the cough measures in discriminating the various degrees of airway compromise on the PA scale score was computed. Sensitivity, specifi city and likelihood ratios, and receiver operator curves (ROCs) were derived. In the analysis, the dependent variable was grouped into three groups to determine if voluntary cough measures from the airfl ow signal were sensitive and specifi c to detect differences between no PA and penetration or aspiration. The three groups based on scores from the 3-oz sequential swallow task were: no PA (PA scale score, 1), presence of penetration (PA scale score, 2-5), and presence of aspiration (PA scale score, 6-8). To evaluate the ability of the various cough airfl ow measures to discriminate across the range of PA scale scoregroupings, ROCs were constructed with groupings of PA relationship between impairment in cough and swallow exists, a patient who is aspirating material is at more risk because it is likely that the patient's cough is also impaired. Even with our sample size and low event rates for penetration and aspiration, these pilot data provide valuable insights into the role of cough in examining upper airway competency. All four of the variables (CPD, EPRT, EPPF, and CVA) were successful at accurately detecting PA on the VFSE. EPPF was also successful at accurately detecting the presence of aspiration above the chance level. This variable showed a fair discriminative ability, with an AUC of 0.88. Even with the small rate
Discussion
The primary aim of this project was to determine if objective measures derived from an airfl ow waveform produced during voluntary cough could accurately detect at-risk patients with PD. Features of the cough airfl ow waveform did indeed relate to PA as judged from VFSE during a 3-oz swallow task for this particular sample of participants with PD of moderate severity. To our knowledge, this is the fi rst study to evaluate the discriminative ability of voluntary cough airfl ow characteristics to model airway compromise in people with PD. Further understanding of airway compromise is important because if the theorized cifi c analysis of cough is needed for it to be useful in detecting PA. For ease of clinical use, our focus has turned to EPPF, which has been reported to be a strong indicator of swallow change in patients with PD and stroke. It is the only portion of the cough signal that can be easily measured with a hand-held peak-fl ow device that could theoretically be used at a patient's bedside to collect its measurement. Our current studies are focusing on providing clinicians with normative values in multiple clinical populations to help ascertain risk at bedside. This research may distinguish EPPF as a robust clinical measure that could easily be added to the bedside evaluation of swallowing.
Conclusions
Aspiration pneumonia is the leading cause of death in people with PD. 13, 14 This pilot project is, to our knowledge, the fi rst to determine the accuracy of detecting the presence of PA judged from VFSE during a 3-oz swallow task, based on changes in airfl ow waveform measures collected during voluntary cough in patients with PD. Our results demonstrate that the four cough variables accurately detected healthy swallows vs PA. Additionally, EPPF emerged as a measure that may be useful in determining aspiration risk in multiple patient populations. Future studies should examine larger cohorts of patients with a greater diversity of disease severity and the presence of dysphagia to determine if the value of EPPF will continue to model airway protection or if a stronger cough feature will emerge.
Acknowledgments
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